Delivery of Anticancer Molecules Using Carbon Nanotubes
Since their discovery in 1991, carbon nanotubes (CNTs) have emerged as material structures with numerous potential applications with a number of products already in the market place. An exciting application, which is emerging, is the use of carbon nanotubes for drug delivery. In this chapter, we focus on the functionalization, mechanism of cellular update, and using carbon nanotubes for delivery of anticancer drugs.
- 9.Elhissi, A. M., Ahmed, W., Ul Hassan, I., Dhanak, V. R., & D’Emanuele, A. (2012). Carbon nanotubes in cancer therapy and drug delivery. Journal of Drug Delivery, 2012. Article ID 837327.Google Scholar
- 17.Van Tassel, K., & Goldman, R. (2010). Manufacturing the wings of icarus: FDA regulation of nanotechnology used in products for human consumption including food, dietary supplements, cosmetics and sunscreens. Journal of Law, Technology and Policy, 32, 2140–2183.Google Scholar
- 23.Nie, H., Wei, G., Yuan, Y., Dou, Z., Zujin, S., Liu, Z., et al. (2010). PEGylation of double-walled carbon nanotubes for increasing their solubility in water. Nanoresearch, 3, 103–109.Google Scholar
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (http://creativecommons.org/licenses/by-nc/2.5/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.